AQR Capital Management - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 47 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$81,000
-34.7%
12,977
-21.8%
0.00%
Q4 2020$124,000
-6.1%
16,591
-23.8%
0.00%
Q3 2020$132,000
-21.9%
21,759
+5.8%
0.00%
Q3 2018$169,000
+0.6%
20,560
+27.5%
0.00%
Q2 2018$168,00016,1310.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders